Creo Medical Limited (CREO.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In GBp
Address
Unit 2, Creo House
Chepstow, NP16 5UH
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 1291 606005
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
278
First IPO Date
December 09, 2016
| Name | Title | Pay | Year Born |
| Craig Jonathan Gulliford | Chief Executive Officer & Executive Director | 502,537 | 1970 |
| Christopher Paul Hancock | Founder & CTO | 127,269 | 1967 |
| David Gerard Woods | Chief Commercial Officer | 152,835 | 1965 |
| Richard John Rees | Chief Financial Officer & Executive Director | 350,411 | 1976 |
| Richard Gary Craven | Secretary | 0 | N/A |
| Phil Hales | Sales & Marketing Director | 0 | N/A |
Creo Medical Limited, a UK-based enterprise and subsidiary of Creo Medical Group plc, specializes in the innovation and creation of electrosurgical medical devices for surgical endoscopy applications. Founded in 2003 as MicroOncology Ltd and headquartered in Chepstow, the company's core offering is Croma, an advanced energy platform. This platform is engineered to power a diverse collection of multi-modal instruments, thereby enhancing therapeutic interventions for both medical professionals and patients. Its extensive product portfolio includes specialized tools such as Speedboat Inject, an adaptable energy instrument designed for flexible endoscopic procedures; Speedboat Slim, a flexible bipolar radiofrequency (RF) and microwave device for precise tissue cutting and coagulation; MicroBlate Fine, a microwave needle for ablation; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device engineered to control upper and lower gastrointestinal bleeds; and SpydrBlade Flex, a flexible scissor-like instrument that integrates bipolar RF and microwave technology to grasp, cut, and coagulate highly vascularized tissues.